The following list contains drafts of proposed guidance documents. In an effort to get fair and balanced input from the veterinary biologics industry prior to finalizing guidance documents, the CVB posts selected draft guidance documents for a 3-week comment period. See CVB Notice 05-16.
If you wish to have your comments on any of the draft documents listed below considered by the CVB, use the following procedure:
1) Submit comments by e-mail addressed to firstname.lastname@example.org.
2) Format the subject line of the e-mail to read "Comments on draft notice/memo <insert ID number>"
3) Submit comments by 12:00 PM (central time) on the due date indicated for each document.
4) The CVB will acknowledge receipt of the comments by return e-mail. Responses to e-mail content will not be provided.
|Veterinary Services Memoranda|
|Licensing Guidelines for Production Platform Technology-Based, Non-Replicating, Nonviable Vaccines||601||
|Prescription Platform Product Biologics||602||
December 26, 2017